您的当前位置:
首页 >
研究报告 >
公司调研 > 预览报告
{{Name}}
公司法人:{{CEO}}
成立日期:{{BirthDate}}
管理规模:{{Scale}}
管理产品:{{ProdCount}}只
{"InnerBanner":null,"MbPageUrl":"/m/Datums/Report?id=5956312","PageTitle":"出售HLX02部分海外权益,生物药研发实力再获证明-公司调研 - 研究报告","Redirect":null,"Data":{"Uploader":{"ID":46,"Face":"/_files/face/0/4ic05hz2.jpg","UName":"韩修齐","UpArts":0,"UpRpts":23470,"UpLbies":24},"Rid":5956312,"IsPdf":true,"IsExist":true,"PdfUrl":"/download2.mtachn.com/upload/report/公司调研/20180622-西南证券-复星医药-600196.SH-出售HLX02部分海外权益生物药研发实力再获证明.pdf","RePage":-1},"UserInfo":{"ID":0,"UName":null,"Face":null}}